USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Menarini Silicon Biosystems S.p.A.

USPTO PatentsView assignee record - 27 granted patents across 15 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Menarini ranks #11,344 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 15 technology areas.

#11,344
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.3/100)
16.2
avg claims per patent
+8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11344 · Foreign Corporation #11,344 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 27 grants
  • UPPER-Q #11,344/49,997
  • PHOTO-FINISH Marposs Societa'…
  • CPC-FOCUS G01N · 15 areas
  • INNOV-PAR 40.3/100
  • CLAIMS-RICH 16.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Marposs Societa' Per Azioni (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Menarini

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Menarini's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Menarini's grants concentrate

Menarini Silicon Biosystems S.p.A. is a focused PatentsView assignee: 15 CPC subclasses with 63% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2016. By volume, Menarini sits between MLS ACQ, Inc. and Miracor Medical SA.

Menarini's three-year grant acceleration

Menarini Silicon Biosystems S.p.A. shows 8 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Menarini's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Menarini holds 27 patents at rank #11,347, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Menarini

By rank, the assignees closest to #11,347 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Menarini's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Menarini, neither rank-band nor same-CPC leaders (those blocks stay above).

Menarini's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201620172018201920202021202220232024 4
USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Menarini Silicon Biosystems S.p.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 3.7%
2017 3 11.1%
2018 5 18.5%
2019 4 14.8%
2020 1 3.7%
2021 5 18.5%
2022 2 7.4%
2023 2 7.4%
2024 4 14.8%

Which technologies does Menarini Silicon Biosystems S.p.A. patent most?

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#11,344

of 49,997 tracked assignees

Innovation Score

40.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Menarini Silicon Biosystems S.p.A.'s patent record in context - here's where to go next.

  • Menarini Silicon Biosystems S.p.A.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 63% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #11,344 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Menarini Silicon Biosystems S.p.A. against MLS ACQ, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.